Kimi Iguchi
Director of Finance/CFO bei SAGE THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Kimi Iguchi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAGE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.03.2013 | - |
Director of Finance/CFO | 01.03.2013 | - | |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 25.10.2018 | - |
Karriereverlauf von Kimi Iguchi
Ehemalige bekannte Positionen von Kimi Iguchi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01.04.2008 | 01.09.2011 |
Cyberkinetics Neurotechnology Systems, Inc. | Director of Finance/CFO | 01.08.2004 | 31.05.2007 |
BIOGEN INC. | Corporate Officer/Principal | 01.01.1996 | 01.01.1998 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01.01.1987 | 01.01.1995 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 07.08.2013 | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 07.08.2013 | - |
Corporate Officer/Principal | 01.01.1998 | 07.08.2013 |
Ausbildung von Kimi Iguchi
Drew University | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Frankreich | 2 |
2 |
Operativ
Director of Finance/CFO | 4 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BIOGEN INC. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
Private Unternehmen | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc. | |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Kimi Iguchi
- Erfahrung